ATRA — Atara Biotherapeutics Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareSpeculativeSmall CapTurnaround

Annual balance sheet for Atara Biotherapeutics, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st
Period Length:	—	—	—	—	—
Source:	10-K	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	501	371	243	51.7	42.5
Net Total Accounts Receivable
Net Total Receivables	1.25	0.986	40.2	34.1	1.48
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets	523	385	295	102	64.9
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	62.8	79.9	74.3	58.8	41.1
Other Long Term Assets
Total Assets	588	468	376	166	109
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	82.9	106	78.9	142	135
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Liabilities	126	189	250	265	206
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity	462	280	127	-99.2	-97.3
Total Liabilities & Shareholders' Equity	588	468	376	166	109
Total Common Shares Outstanding